Detail page

Knowledge Web

Person

Bernhard Scheiner (1989-)

Arzt

Name	Bernhard Scheiner
Time	1989- (Date of birth and death)
Place	Wien (Wirkungsort) Österreich
Gender	männlich
Academic degree	Dr.med.univ. Dr.scient.med.
Profession	Arzt (characteristic profession) Internist
Variant	B. Scheiner
Related	Universitätsklinik für Innere Medizin III (Wien)
Source	https://www.meduniwien.ac.at/web/forschung/researcher-of-the-month/2023-februar-bernhard-scheiner/ (Stand: 02.02.2023)
Record type	Person
GND-Identifier	1279849665
Record ID	1279849665
Involved in show all A meta-analysis and real-world cohort study on the sex-related differences in efficacy and safety of immunotherapy for hepatocellular carcinoma Von Willebrand factor processing in patients with advanced chronic liver disease and its relation to portal hypertension and clinical outcome Austrian consensus on the diagnosis and management of portal hypertension in advanced chronic liver disease (Billroth IV) Clinical characteristics and outcome of patients with combined hepatocellular-cholangiocarcinoma — a European multicenter cohort Imaging features facilitate diagnosis of porto-sinusoidal vascular disorder Covered Transjugular Intrahepatic Portosystemic Shunt Improves Hypersplenism-Associated Cytopenia in Cirrhosis Efficacy and safety of atezolizumab and bevacizumab in the real-world treatment of advanced hepatocellular carcinoma: Experience from four tertiary centers Distinct prognostic value of different portal hypertension-associated features in patients with primary biliary cholangitis The differential activation of cardiovascular hormones across distinct stages of portal hypertension predicts clinical outcomes Vitamin A levels reflect disease severity and portal hypertension in patients with cirrhosis Thromboelastometry in patients with advanced chronic liver disease stratified by severity of portal hypertension Portal hypertensive gastropathy is associated with iron deficiency anemia Hepatic Steatosis in Lean Patients: Risk Factors and Impact on Mortality Patterns and prevalence of dyslipidemia in patients with different etiologies of chronic liver disease Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal Hypertension Progress in eradication of HCV in HIV positive patients with significant liver fibrosis in Vienna

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Bernhard Scheiner (1989-)

A meta-analysis and real-world cohort study on the sex-related differences in efficacy and safety of immunotherapy for hepatocellular carcinoma

Von Willebrand factor processing in patients with advanced chronic liver disease and its relation to portal hypertension and clinical outcome

Austrian consensus on the diagnosis and management of portal hypertension in advanced chronic liver disease (Billroth IV)

Clinical characteristics and outcome of patients with combined hepatocellular-cholangiocarcinoma — a European multicenter cohort

Imaging features facilitate diagnosis of porto-sinusoidal vascular disorder

Covered Transjugular Intrahepatic Portosystemic Shunt Improves Hypersplenism-Associated Cytopenia in Cirrhosis

Efficacy and safety of atezolizumab and bevacizumab in the real-world treatment of advanced hepatocellular carcinoma: Experience from four tertiary centers

Distinct prognostic value of different portal hypertension-associated features in patients with primary biliary cholangitis

The differential activation of cardiovascular hormones across distinct stages of portal hypertension predicts clinical outcomes

Vitamin A levels reflect disease severity and portal hypertension in patients with cirrhosis

Thromboelastometry in patients with advanced chronic liver disease stratified by severity of portal hypertension

Portal hypertensive gastropathy is associated with iron deficiency anemia

Hepatic Steatosis in Lean Patients: Risk Factors and Impact on Mortality

Patterns and prevalence of dyslipidemia in patients with different etiologies of chronic liver disease

Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal Hypertension

Progress in eradication of HCV in HIV positive patients with significant liver fibrosis in Vienna